Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Identification of U11snRNA as an endogenous agonist of TLR7-mediated immune pathogenesis.

Negishi H, Endo N, Nakajima Y, Nishiyama T, Tabunoki Y, Nishio J, Koshiba R, Matsuda A, Matsuki K, Okamura T, Negishi-Koga T, Ichinohe T, Takemura S, Ishiwata H, Iemura SI, Natsume T, Abe T, Kiyonari H, Doi T, Hangai S, Yanai H, Fujio K, Yamamoto K, Taniguchi T.

Proc Natl Acad Sci U S A. 2019 Nov 6. pii: 201915326. doi: 10.1073/pnas.1915326116. [Epub ahead of print]

PMID:
31694883
2.

The RNA-binding protein Mex-3B plays critical roles in the development of steroid-resistant neutrophilic airway inflammation.

Yamazumi Y, Sasaki O, Suyama-Fuchino S, Kohu K, Kamoshida Y, Harada H, Fujio K, Oda T, Akiyama T.

Biochem Biophys Res Commun. 2019 Nov 5;519(2):220-226. doi: 10.1016/j.bbrc.2019.08.158. Epub 2019 Sep 4.

PMID:
31493864
3.

Eosinophilic cholangitis with eosinophilic granulomatosis with polyangiitis: A case report and review of the literature.

Yoshihara R, Komai T, Nagafuchi Y, Tsuchida Y, Shoda H, Tanaka M, Ushiku T, Fujio K.

Allergol Int. 2019 Aug 31. pii: S1323-8930(19)30131-5. doi: 10.1016/j.alit.2019.08.002. [Epub ahead of print] No abstract available.

4.

Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity.

Sawada T, Kurano M, Shirai H, Iwasaki Y, Tahara K, Hayashi H, Igarashi K, Fujio K, Aoki J, Yatomi Y.

Int J Rheum Dis. 2019 Nov;22(11):2059-2066. doi: 10.1111/1756-185X.13689. Epub 2019 Aug 30.

PMID:
31468739
5.

CD4+CD25+LAG3+ T Cells With a Feature of Th17 Cells Associated With Systemic Lupus Erythematosus Disease Activity.

Kato R, Sumitomo S, Tsuchida Y, Tsuchiya H, Nakachi S, Sakurai K, Hanata N, Nagafuchi Y, Kubo K, Tateishi S, Kanda H, Okamura T, Yamamoto K, Fujio K.

Front Immunol. 2019 Jul 12;10:1619. doi: 10.3389/fimmu.2019.01619. eCollection 2019.

6.

Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.

Nakano M, Kubo K, Shirota Y, Iwasaki Y, Takahashi Y, Igari T, Inaba Y, Takeshima Y, Tateishi S, Yamashita H, Miyazaki M, Sato H, Kanda H, Kaneko H, Ishii T, Fujio K, Tanaka N, Mimori A.

Lupus. 2019 Aug;28(9):1062-1073. doi: 10.1177/0961203319860200. Epub 2019 Jul 11. Erratum in: Lupus. 2019 Aug 23;:961203319869574.

7.

Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector.

Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, Natsumoto B, Fujio K, Kumaki E, Okano T, Ono S, Tanita K, Morio T, Kanegane H, Hasegawa H, Mizoguchi F, Kawahata K, Kohsaka H, Moritake H, Nunoi H, Waki H, Tamaru SI, Sasako T, Yamauchi T, Kadowaki T, Tanaka H, Kitanaka S, Nishimura K, Ohtaka M, Nakanishi M, Otsu M.

Stem Cell Res Ther. 2019 Jun 24;10(1):185. doi: 10.1186/s13287-019-1273-2.

8.

Improving the Micropore Capacity of Activated Carbon by Preparation under a High Magnetic Field of 10 T.

Hamasaki A, Furuse A, Sekinuma Y, Fujio K, Iide M, Ozeki S.

Sci Rep. 2019 May 16;9(1):7489. doi: 10.1038/s41598-019-43818-y.

9.

Evaluation of response criteria in rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs.

Inoue M, Kanda H, Tateishi S, Fujio K.

Arthritis Care Res (Hoboken). 2019 May 6. doi: 10.1002/acr.23914. [Epub ahead of print]

PMID:
31058442
10.

Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus.

Takeshima Y, Iwasaki Y, Fujio K, Yamamoto K.

Semin Arthritis Rheum. 2019 Jun;48(6):1142-1145. doi: 10.1016/j.semarthrit.2019.04.006. Epub 2019 Apr 25.

PMID:
31056210
11.

New horizons in clinical immunology: applications of induced pluripotent stem cells for the analysis of immune disorders.

Shoda H, Natsumoto B, Fujio K.

Immunol Med. 2018 Mar;41(1):12-16. doi: 10.1080/09114300.2018.1451596. Epub 2018 Apr 4.

PMID:
30938253
12.

Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus.

Nagafuchi Y, Shoda H, Fujio K.

Cells. 2019 Feb 10;8(2). pii: E140. doi: 10.3390/cells8020140. Review.

13.

Presetting of the Corticospinal Excitability in the Tibialis Anterior Muscle in Relation to Prediction of the Magnitude and Direction of Postural Perturbations.

Fujio K, Obata H, Kawashima N, Nakazawa K.

Front Hum Neurosci. 2019 Jan 17;13:4. doi: 10.3389/fnhum.2019.00004. eCollection 2019.

14.

Molecular and functional heterogeneity of IL-10-producing CD4+ T cells.

Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi SM, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki JR, Lohse AW, Flavell RA, Krebs C, Gustafsson JA, Antonson P, Roncarolo MG, Villablanca EJ, Gagliani N, Huber S.

Nat Commun. 2018 Dec 21;9(1):5457. doi: 10.1038/s41467-018-07581-4.

15.

Factors associated with discontinuation of glucocorticoids after starting biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients.

Inoue M, Kanda H, Tateishi S, Fujio K.

Mod Rheumatol. 2018 Nov 28:1-15. doi: 10.1080/14397595.2018.1553264. [Epub ahead of print]

PMID:
30484724
16.

Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review.

Sumitomo S, Nagafuchi Y, Tsuchida Y, Tsuchiya H, Ota M, Ishigaki K, Suzuki A, Kochi Y, Fujio K, Yamamoto K.

Inflamm Regen. 2018 Nov 5;38:21. doi: 10.1186/s41232-018-0078-5. eCollection 2018. Review.

17.

The Optimal Suture Placement and Bone Tunnels for TFCC Repair: A Cadaveric Study.

Matsumoto T, Tang P, Fujio K, Strauch RJ, Rosenwasser MP.

J Wrist Surg. 2018 Nov;7(5):375-381. doi: 10.1055/s-0038-1661361. Epub 2018 Jun 26.

18.

Retro-odontoid Pseudotumor Associated with Sjögren Syndrome and Systemic Lupus Erythematosus Serology.

Yamada S, Nagafuchi Y, Fujio K.

J Rheumatol. 2018 Oct;45(10):1424-1425. doi: 10.3899/jrheum.171251. No abstract available.

PMID:
30275341
19.

Rupture of a Calyceal Diverticulum Secondary to Ureteroscopy: A Rare Complication.

Yamasaki T, Yoshioka T, Imoto M, Aoki H, Fujio K, Uehara S, Otsuki H.

Case Rep Urol. 2018 Jul 9;2018:9285671. doi: 10.1155/2018/9285671. eCollection 2018.

20.

Reevaluation of Pluripotent Cytokine TGF-β3 in Immunity.

Komai T, Okamura T, Inoue M, Yamamoto K, Fujio K.

Int J Mol Sci. 2018 Aug 1;19(8). pii: E2261. doi: 10.3390/ijms19082261. Review.

21.

Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study.

Tanaka Y, Kameda H, Saito K, Kaneko Y, Tanaka E, Yasuda S, Tamura N, Fujio K, Fujii T, Kojima T, Anzai T, Hamada C, Fujino Y, Matsuda S, Kohsaka H.

Arthritis Res Ther. 2018 Jul 20;20(1):151. doi: 10.1186/s13075-018-1647-3.

22.

Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.

Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K.

Cell. 2018 Jul 26;174(3):636-648.e18. doi: 10.1016/j.cell.2018.06.011. Epub 2018 Jul 12.

23.

Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals.

Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K.

Front Immunol. 2018 Jun 14;9:1364. doi: 10.3389/fimmu.2018.01364. eCollection 2018.

24.

Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam et al.

Tsuchida Y, Sumitomo S, Ota M, Tsuchiya H, Nagafuchi Y, Shoda H, Fujio K, Ishigaki K, Yamaguchi K, Suzuki A, Kochi Y, Yamamoto K.

Arthritis Rheumatol. 2018 Oct;70(10):1695-1696. doi: 10.1002/art.40652. No abstract available.

25.

Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.

Sato T, Hatano M, Iwasaki Y, Maki H, Saito A, Minatsuki S, Inaba T, Amiya E, Fujio K, Watanabe M, Yamamoto K, Komuro I.

PLoS One. 2018 May 15;13(5):e0197297. doi: 10.1371/journal.pone.0197297. eCollection 2018.

26.

[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Pathogenesis of Rheumatoid Arthritis.]

Fujio K.

Clin Calcium. 2018;28(5):601-606. doi: CliCa1805601606. Japanese.

PMID:
29731452
27.

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells.

Teruya S, Okamura T, Komai T, Inoue M, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K.

Sci Rep. 2018 May 4;8(1):7021. doi: 10.1038/s41598-018-25302-1.

28.

HLA-DRB1 Shared Epitope Alleles and Disease Activity Are Correlated with Reduced T Cell Receptor Repertoire Diversity in CD4+ T Cells in Rheumatoid Arthritis.

Sakurai K, Ishigaki K, Shoda H, Nagafuchi Y, Tsuchida Y, Sumitomo S, Kanda H, Suzuki A, Kochi Y, Yamamoto K, Fujio K.

J Rheumatol. 2018 Jul;45(7):905-914. doi: 10.3899/jrheum.170909. Epub 2018 Apr 15.

PMID:
29657145
29.

Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases.

Okamura T, Yamamoto K, Fujio K.

Front Immunol. 2018 Feb 26;9:340. doi: 10.3389/fimmu.2018.00340. eCollection 2018. Review.

30.

Corticospinal Excitability Is Modulated as a Function of Postural Perturbation Predictability.

Fujio K, Obata H, Kitamura T, Kawashima N, Nakazawa K.

Front Hum Neurosci. 2018 Feb 27;12:68. doi: 10.3389/fnhum.2018.00068. eCollection 2018.

31.

Rhabdomyolysis Induced by Isoniazid in a Patient with Rheumatoid Arthritis and End-stage Renal Disease: A Case Report and Review of the Literature.

Komai T, Sumitomo S, Teruya S, Fujio K.

Intern Med. 2018 Aug 15;57(16):2413-2416. doi: 10.2169/internalmedicine.0463-17. Epub 2018 Mar 9. Review.

32.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
33.

Tofacitinib rapidly ameliorated polyarthropathy in a patient with systemic sclerosis.

Komai T, Shoda H, Hanata N, Fujio K.

Scand J Rheumatol. 2018 Nov;47(6):505-506. doi: 10.1080/03009742.2017.1387673. Epub 2017 Dec 20. No abstract available.

PMID:
29260607
34.

Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.

Atsumi T, Fujio K, Yamaoka K, Tomobe M, Kuroyanagi K, Kameda H.

Mod Rheumatol. 2018 Sep;28(5):780-788. doi: 10.1080/14397595.2017.1416760. Epub 2018 Jan 8.

35.

A gene module associated with dysregulated TCR signaling pathways in CD4+ T cell subsets in rheumatoid arthritis.

Sumitomo S, Nagafuchi Y, Tsuchida Y, Tsuchiya H, Ota M, Ishigaki K, Nakachi S, Kato R, Sakurai K, Hanata N, Tateishi S, Kanda H, Suzuki A, Kochi Y, Fujio K, Yamamoto K.

J Autoimmun. 2018 May;89:21-29. doi: 10.1016/j.jaut.2017.11.001. Epub 2017 Nov 13.

PMID:
29146547
36.

Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.

Tsukui D, Kanda H, Shinozaki-Ushiku A, Tateishi S, Takeshima Y, Nagafuchi Y, Sasaki O, Iwasaki Y, Harada H, Shibuya M, Sumitomo S, Shoda H, Kubo K, Fujio K, Nakamura F, Kurokawa M, Fukayama M, Yamamoto K.

Mod Rheumatol. 2018 Jul;28(4):621-625. doi: 10.1080/14397595.2017.1387223. Epub 2017 Oct 23.

PMID:
29057700
37.

Arthroscopic Management of Triangular Fibrocartilage Complex Foveal Injury.

Fujio K.

Hand Clin. 2017 Nov;33(4):619-624. doi: 10.1016/j.hcl.2017.07.009. Review.

PMID:
28991574
38.

Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells.

Fujio K, Yamamoto K, Okamura T.

Curr Top Microbiol Immunol. 2017;410:29-45. doi: 10.1007/82_2017_59. Review.

PMID:
28929191
39.

Robotic Renal Autotransplantation: First Case Outside of North America.

Araki M, Wada K, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Yoshioka T, Ariyoshi Y, Fujio K, Takamoto A, Sugimoto M, Sasaki K, Kobayashi Y, Ebara S, Taninishi H, Amano H, Inui M, Watanabe M, Watanabe T, Nasu Y.

Acta Med Okayama. 2017 Aug;71(4):351-355. doi: 10.18926/AMO/55313.

40.

Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis.

Shoda H, Nagafuchi Y, Tsuchida Y, Sakurai K, Sumitomo S, Fujio K, Yamamoto K.

Arthritis Res Ther. 2017 May 31;19(1):111. doi: 10.1186/s13075-017-1308-y.

41.

Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis.

Ishigaki K, Kochi Y, Suzuki A, Tsuchida Y, Tsuchiya H, Sumitomo S, Yamaguchi K, Nagafuchi Y, Nakachi S, Kato R, Sakurai K, Shoda H, Ikari K, Taniguchi A, Yamanaka H, Miya F, Tsunoda T, Okada Y, Momozawa Y, Kamatani Y, Yamada R, Kubo M, Fujio K, Yamamoto K.

Nat Genet. 2017 Jul;49(7):1120-1125. doi: 10.1038/ng.3885. Epub 2017 May 29.

PMID:
28553958
42.

Investigation of the pathogenesis of autoimmune diseases by iPS cells.

Natsumoto B, Shoda H, Fujio K, Otsu M, Yamamoto K.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):48-53. doi: 10.2177/jsci.40.48. Review. Japanese.

43.

The metabolic regulation in immune cells and pathogenesis of systemic lupus erythematosus ∼toward new therapeutic applications∼.

Takeshima Y, Iwasaki Y, Okamura T, Fujio K, Yamamoto K.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):12-20. doi: 10.2177/jsci.40.12. Review. Japanese.

44.

Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis.

Nakachi S, Sumitomo S, Tsuchida Y, Tsuchiya H, Kono M, Kato R, Sakurai K, Hanata N, Nagafuchi Y, Tateishi S, Kanda H, Okamura T, Yamamoto K, Fujio K.

Arthritis Res Ther. 2017 May 16;19(1):97. doi: 10.1186/s13075-017-1309-x.

45.

Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis.

Sakurai K, Kubo K, Kanda H, Fujio K, Yamamoto K.

Int J Rheum Dis. 2017 Dec;20(12):2214-2216. doi: 10.1111/1756-185X.13024. Epub 2017 Feb 16. No abstract available.

PMID:
28205382
46.

Enhanced gut homing receptor expression of unswitched memory B cells in rheumatoid arthritis.

Nagafuchi Y, Shoda H, Sumitomo S, Nakachi S, Kato R, Tsuchida Y, Tsuchiya H, Sakurai K, Hanata N, Tateishi S, Kanda H, Fujio K, Yamamoto K.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):354-355. Epub 2017 Jan 27.

PMID:
28134080
47.

TGF-β3 Inhibits Antibody Production by Human B Cells.

Tsuchida Y, Sumitomo S, Ishigaki K, Suzuki A, Kochi Y, Tsuchiya H, Ota M, Komai T, Inoue M, Morita K, Okamura T, Yamamoto K, Fujio K.

PLoS One. 2017 Jan 4;12(1):e0169646. doi: 10.1371/journal.pone.0169646. eCollection 2017.

48.

Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.

Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8131-E8140. Epub 2016 Nov 30.

49.

Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity.

Morita K, Okamura T, Sumitomo S, Iwasaki Y, Fujio K, Yamamoto K.

Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii76-ii81. Review.

PMID:
27856665
50.

Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still's disease.

Tsuchida Y, Sumitomo S, Shoda H, Kubo K, Fujio K, Yamamoto K.

Mod Rheumatol. 2017 May;27(3):556-557. doi: 10.1080/14397595.2016.1221875. Epub 2016 Oct 25. No abstract available.

PMID:
27778518

Supplemental Content

Support Center